Atara Biotherapeutics Inc. buy BiotechBee
Start price
01.10.23
/
50%
€1.41
Target price
31.01.26
€3.00
Performance (%)
-74.00%
End price
08.09.24
-
Summary
This prediction is currently being closed. Massive losses of -74.00% have been the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atara Biotherapeutics Inc. | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
According to BiotechBee what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year